BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30035819)

  • 21. Prediction of nonsentinel lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
    Öz B; Akcan A; Doğan S; Abdulrezzak Ü; Aslan D; Sözüer E; Emek E; Akyüz M; Elmalı F; Ok E
    Asian J Surg; 2018 Jan; 41(1):12-19. PubMed ID: 27591153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
    Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
    Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
    Martín-Sánchez E; Pernaut-Leza E; Mendaza S; Cordoba A; Vicente-Garcia F; Monreal-Santesteban I; Vizcaino JP; De Cerio MJ; Perez-Janices N; Blanco-Luquin I; Escors D; Ulazia-Garmendia A; Guerrero-Setas D
    Virchows Arch; 2016 Jul; 469(1):51-9. PubMed ID: 27097811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of sentinel lymph node biopsy for the assessment of axillary status in patients with early (T1) breast carcinoma.
    Gurleyik G; Aker F; Sekmen U; Saglam A
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):697-700. PubMed ID: 16300705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
    Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
    Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients.
    Rubio IT; Espinosa-Bravo M; Rodrigo M; Amparo Viguri Diaz M; Hardisson D; Sagasta A; Dueñas B; Peg V
    Breast Cancer Res Treat; 2014 Sep; 147(2):371-80. PubMed ID: 25164972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
    Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
    J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drainage of Tumor-Derived DNA into Sentinel Lymph Nodes in Breast Cancer Patients.
    Miyamura Y; Kagara N; Miyake T; Tanei T; Naoi Y; Shimoda M; Shimazu K; Kim SJ; Noguchi S
    Pathol Oncol Res; 2019 Oct; 25(4):1635-1643. PubMed ID: 30805870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.
    Piñero-Madrona A; Ruiz-Merino G; Bernet L; Miguel-Martínez B; Vicente-García F; Viguri-Díaz MA; Giménez-Climent J
    Breast; 2014 Dec; 23(6):859-64. PubMed ID: 25283682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node pressure in breast cancer.
    Nathanson SD; Mahan M
    Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Santoro A; Angelico G; Inzani F; Arciuolo D; Spadola S; Valente M; D'Alessandris N; Piermattei A; Fiorentino V; CIanfrini F; Bizzarri N; Pedone Anchora L; Fagotti A; Scambia G; Zannoni GF
    Int J Gynecol Cancer; 2020 Dec; 30(12):1871-1877. PubMed ID: 33127865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
    Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
    Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
    Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.